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Virulence of Newcastle disease virus (NDV) is mainly determined by the amino acid sequence
of the fusion (F0) protein cleavage site. Full-length NDV cDNA clone pNDFL was used to generate
infectious NDV with defined mutations in the F0 cleavage site (RRQRRQL, GRQGRQF,
RRQGRQF, RGQRRQF and RKQKRQF). All the mutants were viable and the mutations
were maintained after virus propagation in embryonated eggs. The mutants showed single-cell
infections on chicken embryo fibroblasts, which suggested that they were non-virulent. However,
virulence tests in 1-day-old chickens resulted in an intracerebral pathogenicity index (ICPI) between
0 and 1?3. Moreover, virulent virus was isolated from chickens that had died in the virulence tests.
Subsequent sequence analysis showed that the mutants RRQRRQL, RRQGRQF, RGQRRQF
and RKQKRQF gave rise to the appearance of revertants containing the virulent cleavage site
RRQ(K/R)RQF and an ICPI of 1?4 or higher. This indicated that reversion to virulence was caused
by alteration of the amino acid sequence of the F0 cleavage site from a non-virulent to a virulent type.
Furthermore, the ICPI of the revertants was higher than that of cDNA-derived strain NDFLtag, which
has the same cleavage site, RRQRRQF (ICPI51?3). NDFLtagPass, which was isolated from dead
chickens after intracerebral inoculation of NDFLtag, also showed an increase in the ICPI from 1?3 to
1?5. This study proves that reversion to virulence occurs within non-virulent NDV populations and
that the virulence may increase after one passage in chicken brain.
INTRODUCTION
Newcastle disease is a serious disease in many species of
birds, both domestic and wild. Because chickens are the
most susceptible birds, the disease can cause serious econo-
mic problems in the poultry industry worldwide (Alexander,
2000, 2001). The virus that causes this avian disease is
Newcastle disease virus (NDV) a member of the Rubulavirus
genus of the subfamily Paramyxovirinae (family Paramyxo-
viridae, order Mononegavirales) (Murphy et al., 1995).
However, recent studies suggest that NDV should be
assigned to a new genus (de Leeuw & Peeters, 1999; Seal
et al., 2000; Westover & Hughes, 2001).
NDV contains a non-segmented single-stranded RNA
genome of negative polarity with a size of 15 186 nucleo-
tides (Krishnamurthy & Samal, 1998; de Leeuw & Peeters,
1999; Phillips et al., 1998; Ro¨mer-Oberdorfer et al., 1999)
and contains six genes encoding the nucleocapsid protein
(NP), phosphoprotein (P), matrix protein (M), fusion
protein (F), haemagglutinin–neuraminidase protein (HN)
and large polymerase protein (L) (Lamb & Kolakofsky,
1996).
NDV is an enveloped virus with two membrane proteins,
one of which is involved in cell attachment and release (HN
protein) and the other in mediating fusion of the viral
envelope with cellular membranes (F protein). The F protein
is synthesized as a precursor, F0, and is only fusogenic after
cleavage into disulfide-linked F1 and F2 polypeptides. This
cleavage is accomplished by host-cell proteases (Nagai
et al., 1976; Morrison et al., 1985; Ogasawara et al., 1992).
Thus, NDV becomes infective only when the precursor
glycoprotein F0 is cleaved into F1 and F2. The ability to
cleave F0 varies among different strains of NDV and is the
main determinant of mortality and morbidity in infected
chickens. Using mean death time (MDT) determined in
chicken eggs, NDV strains can be classified as highly viru-
lent (velogenic), intermediate (mesogenic) or non-virulent
(lentogenic) (Beard & Hanson, 1984). Within the highly
virulent NDV strains, two types of virus can be distin-
guished. These strains are termed neurotropic velogenic or
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viscerotropic velogenic, based on the clinical signs induced
(Alexander, 2000).
Phylogenetic studies at the molecular level of the NDV
F0 cleavage site have determined the consensus amino
acid sequence 112R/K-R-Q-R/K-R-F117 for virulent and
mesogenic strains and 112G/E-K/R-Q-G/E-R-L117 for NDV
strains of low virulence (Collins et al., 1993). However, two
exceptions to the consensus amino acid sequence for
virulent strains have been observed for the so-called
pigeon paramyxovirus type 1 (PPMV-1) isolates. These
virulent isolates show fusion protein cleavage sites of
112GRQKRF117 (Collins et al., 1993) and 112RRKKRF117
(Werner et al., 1999).
The different F0 protein cleavage sites are the substrates for
different kinds of cellular proteases (Kawahara et al., 1992;
Sakaguchi et al., 1991). The F0 of lentogenic viruses can be
cleaved only by trypsin-like enzymes, as found in the
respiratory and intestinal tracts, whereas F0 of virulent
viruses can be cleaved by a host protease (or proteases)
found in a wide range of cells and tissues. Consequently,
infection with a virulent strain results in fatal systemic
infection (Garten et al., 1980; Nagai et al., 1976). Until now,
it has not been clear which specific host-cell protease is
responsible for cleavage of the different F0 proteins.
However, velogenic and mesogenic strains show a clear
dibasic amino acid motif (K/R residues at amino acid
positions 112/113 and 115/116) with a phenylalanine (F117)
at the N terminus of the F1 protein after cleavage (Glickman
et al., 1988; Morrison et al., 1993; Toyoda et al., 1987). This
sequence motif is most comparable with the motif of the
furin family of proteases (Fujii et al., 1999; Sakaguchi et al.,
1994). In contrast to the velogenic and mesogenic strains,
lentogenic strains show a monobasic motif and a leucine
(L117) at the N terminus of the F1 protein. This sequence
motif is recognized by a factor X-like protease (vitamin
K-dependent serine protease of the prothrombin family),
which is present in the allantoic fluid and the amniotic fluid
of the chicken egg (Gotoh et al., 1990; Ogasawara et al.,
1992). In conclusion, there is a correlation between viru-
lence or pathogenicity and a high content of basic amino
acid residues at the F0 cleavage site.
The F0 protein is able to induce cell fusion only when the F0
protein is cleaved into F1 and F2. The HN protein is also
needed in the promotion of fusion to co-operate with the F
protein (Deng et al., 1997). Syncytium formation by cells
can be observed when the F0 protein and HN protein are co-
expressed after co-transfection of plasmids containing the F
and HN genes (Li et al., 1998; Peeters et al., 2001). This assay
can be used to examine the effect of specific amino acid
mutations on cleavability of the F0 protein.
Mutagenesis of the amino acids of a velogenic F0 cleavage
site has recently been carried out to investigate which amino
acid mutation influences syncytium formation (cell fusion)
after co-transfection of cultured cells with F and HN genes
(Fujii et al., 1999; Li et al., 1998). These data clearly showed
that the dibasic structure as well as the phenylalanine at
position 117 is necessary for the host-cell protease to cleave
F0 and to form a biologically active complex with the HN
protein. Using reverse genetics techniques, we recently esta-
blished an infectious clone of NDV and we showed that
modification of the lentogenic cleavage site 112GRQGRQL117
into the consensus sequence of virulent strain 112RRQRRQF117
increased the intracerebral pathogenicity index (ICPI) from
0 to 1?3 (Peeters et al., 1999). These results confirmed that
the presence of one or both arginines at positions 112 and
115 and/or the phenylalanine at residue 117 are necessary for
efficient cleavage of the F0 protein and result in an increase
in virulence.
With the already available data on the amino acid sequences
of the F0 cleavage site, we wanted to examine different F0
cleavage site mutations at the whole-virus level. Li et al.
(1998) showed that mutations of the F0 cleavage site such as
K115G, F117L and R113G/K115G were fusion-negative.
However, all mutant F0 proteins activated fusion after the
addition of exogenous trypsin. Thus, it should be possible to
generate viruses with different F0 cleavage sites that can
grow in an environment with trypsin-like proteases (e.g.
allantoic fluid and the amniotic fluid of the embryonated
chicken egg). If it is possible to generate viruses with
mutations of the F0 cleavage site, then the next step is to
investigate the effect of those mutations on virulence and
pathogenesis.
In this study, we have used our full-length NDV cDNA clone
to generate infectious NDV with defined mutations in the F0
protease cleavage site. The following F0 cleavage site mutants
were generated: RRQRRQL, GRQGRQF, RRQGRQF,
RGQRRQF and RKQKRQF. Here, we show that all the
F0 cleavage site mutants were viable and that the mutations
were maintained after virus propagation in embryonated
eggs. The F0 cleavage site mutants were non-virulent based
on plaque assays in cell culture. However, after intracerebral
inoculation in 1-day-old chickens, virulent revertants were
isolated from infected animals.
METHODS
Cells and viruses. QM5 cells (Antin & Ordahl, 1991) were
grown in medium supplied by Gibco BRL/LifeTechnologies (Cat.
no. 041-91536; proprietary composition of Fort Dodge). Primary
chicken embryo fibroblast (CEF) cells were grown in the Glasgow
modification of Eagle’s medium/Eagle’s minimal essential medium
(1 : 1; both from ICN). Both media were supplemented with 5 %
foetal calf serum (FCS) and antibiotics. The fowlpox recombinant
virus fpE-FLT7pol (Britton et al., 1996) (hereafter called FPV-T7),
which expresses T7 RNA polymerase, was grown on primary chicken
embryo liver cells.
The strains NDFL and NDFLtag were obtained from the NDV strain
La Sota (ATCC VR-699), as previously described (Peeters et al., 1999).
Modification of the protease cleavage site of the F0 protein.
All standard cloning procedures were performed as described in
Sambrook et al. (1989), unless otherwise noted. Mutagenesis reac-
tions on the sequence encoding the protease cleavage site of the F0
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protein were carried out using PCR as described previously (Peeters
et al., 1999). The same procedure was used for the new F0 cleavage
mutants, which are listed in Table 1.
The first PCR fragment was generated using the forward
primer NDV5Fxho (59-GAAGCTCGAGGATCCCGGTTGGCAC-39)
and one of the following reverse primers: Ffmr (59-AAGGCG-
CCGCTGTCTCCTCCCTCCAGATGTAGTCAC-39); Ffm1r (59-
AAAGCGCCCCTGTCTCCCCCCTCCAGATGTAGTCAC-39); Ffm2r
(59-AAAGCGCCCCTGTCTCCTCCCTCCAGATGTAGTCAC-39);
Ffm3r (59-AAAGCGCCGCTGTCCCCTCCCTCCAGATGTAGTCAC-39);
Ffm4r (59-AAAGCGCTTCTGTTTCCTCCCTCCAGATGTAGTCAC-39);
or Ffm5r (59-AAAGCGCTTCTGTCTCCTCCCTCCAGATGTAGTCAC-
39). The second PCR fragment was generated using one of the
following forward primers: Ffmf (59-GGAGGAGACAGCGGC-
GCCTTATAGGCGCCATTATTGG-39); Ffm1f (59-GGGGGA-
GACAGGGGCGCTTTATAGGCGCCATTATTGG-39); Ffm2f
(59-GGAGGAGACAGGGGCGCTTTATAGGCGCCATTATTGG-39);
Ffm3f (59-GGAGGGGACAGCGGCGCTTTATAGGCGCCATTATTGG-39);
Ffm4f (59-GGAGGAAACAGAAGCGCTTTATAGGCGCCATTATTGG-39);
or Ffm5f (59-GGAGGAGACAGAAGCGCTTTATAGGCGCCATTATTGG-
39) and the reverse primer NDV3Fmlu (59-TTACACGCGTATT-
GCTATTGGGGATACC-39). The two overlapping PCR fragments
were joined in a second PCR by using primers NDV5Fxho and
NDV3Fmlu. The resulting fragments, which contained the entire open
reading frame of the F gene, were cloned in pCIneo (Promega) between
the XhoI and MluI sites, yielding pCIneo-Ffm, pCIneo-Ffm1, pCIneo-
Ffm2, pCIneo-Ffm3 and pCIneo-Ffm4. In order to introduce the F0
mutations in the full-length NDV cDNA, the StuI–NotI fragment
(nt 4646–4952) of pNDFL (Peeters et al., 1999) was replaced by the
StuI–NotI fragments of the pCIneo constructs FFM–FFM4. The resulting
plasmids were designated pNDFL-Ffm, -Ffm1, -Ffm2, -Ffm3, -Ffm4 and
Ffm5, respectively.
Co-transfections. DNA transfections using Fugene6 were carried
out essentially as recommended by the manufacturer (Roche). QM5
cells were grown in six-well culture dishes and after 24 h the cells
were infected at an m.o.i. of 1 with FPV-T7 for 1 h at 37 C˚. The
cells were washed with PBS and co-transfected with 1 mg of the
various pCIneo-F constucts and 1 mg pCIneo-HN in QM5 medium
containing 5 % allantoic fluid, 5 % FCS and antibiotics. After 48 h,
expression of the F0 protein was verified in an immunoperoxidase
monolayer assay (Wensvoort et al., 1986) using mAb 8E12A8C3
(ID-Lelystad).
Fusion activity of NDV F0 cleavage site mutants was determined
microscopically 48 h post-transfection by examining syncytium
formation of QM5 cells. Before observation, the QM5 cells were
washed with PBS, stained for 30 min with Giemsa (Merck; 1 : 30
dilution in water) and washed again with PBS.
Rescue of infectious virus. To rescue viable virus from the var-
ious full-length pNDFL-F constucts, QM5 cells were infected with
FPV-T7 and co-transfected as describe above. One mg pNDFL-F,
0?8 mg pCIneo-NP, 0?4 mg pCIneo-P and 0?4 mg pCIneo-L were used
for each co-transfection. After 3 days, the culture supernatant was
harvested and inoculated into the allantoic cavities of 8–11-day-old
embryonated specific pathogen-free (SPF) eggs (Peeters et al., 1999).
Haemagglutination (HA) assay and pathogenicity tests. The
HA assay and determination of the intracerebral pathogenicity index
(ICPI) in 1-day-old chickens was performed as described in the
European Community Council Directive 92/66/EEC (14 July 1992).
Re-isolation of virulent virus from dead chickens. Brains,
livers and lungs were collected from three dead chickens and homo-
genized with a mortar and sterile sand in tryptose/phosphate broth
(Invitrogen) with antibiotics. After incubation at room temperature
for 2 h, the organ suspensions of three chickens were pooled and
centrifuged for 10 min at 2500 r.p.m. The supernatant was used for
further virus propagation.
RT-PCR and sequence analysis. To sequence the region of the
F gene that encodes the protease cleavage site, an RT-PCR
fragment was obtained from the viral genome using primer 3UIT
(59-ACCAAACAGAGAATCCGTGAGTTA-39) for reverse trans-
cription and primers NDV5Fxho and NDV3Fmlu for the PCR.
The resulting PCR fragment was purified using a High Pure PCR
Table 1. Nucleotide and deduced amino acid sequences of the region encompassing the F0 cleavage site, and syncytium
formation by QM5 cells after co-transfection with the F0 cleavage site mutants and pCIneo-HNLS
The nucleotide changes that were introduced to modify the amino acid sequences of the cleavage site are underlined. The resulting amino
acid changes are shown in bold. The arrow indicates the site of cleavage.
F0 cleavage site mutant Sequence Syncytium formation
FLS (La Sota) GGG AGA CAG GGG CGC CTT 2
G R Q G R L
FWT (tag) AGG AGA CAG CGG CGC TTT +
R R Q R R F
FFM AGG AGA CAG CGG CGC CTT 2
R R Q R R L
FFM1 GGG AGA CAG GGG CGC TTT 2
G R Q G R F
FFM2 AGG AGA CAG GGG CGC TTT 2
R R Q G R F
FFM3 AGG GGA CAG CGG CGC TTT 2
R G Q R R F
FFM4 AGG AAA CAG AAG CGC TTT 2
R K Q K R F
Amino acid position 112 113 114 115 116Q 117
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purification kit (Roche) and sequenced with primer p4731+ (59-
AAGCTCCTCCCGAATCTGCC-39) using a PRISM kit (Perkin-
Elmer) and an Applied Biosystems AB310 automatic sequencer.
RESULTS
Syncytium formation induced by mutant F0
proteins after co-expression with the HN
protein
Table 1 shows the nucleotide and amino acid sequences of
the NDV F0 cleavage site mutants that we generated. These
mutations have never been observed in any known F0
protein sequence from field isolates.
Mutagenesis of the fusion cleavage site of F0 was performed
by PCR using plasmid pCIneo-FWT (RRQRRQF) as the
template (see Methods). In FWT, the following cleavage site
mutations were introduced: F117L (FFM), R115G (FFM2),
R113G (FFM3), R112G+R115G (FFM1) and R113K+R115K
(FFM4). These five mutant F0 genes were cloned in plasmid
pCIneo.
Expression of the different F0 proteins was controlled by
transfection into QM5 cells followed by immunological
staining of the fixed monolayer with mAb 8E12A8C3
directed against the F protein. Immunological staining of
the expressed (mutant) F0 proteins did not show any
significant differences in the number of positive cells (data
not shown).
To determine whether the F0 mutants were able to induce
syncytium formation, QM5 cells were co-transfected
with the fusion cleavage site mutants and pCIneo-HNLS
(La Sota). None of the F0 cleavage site mutants showed
syncytium formation after 48 h on QM5 cells (Table 1).
Only the positive control pCIneo-FWT showed syncytium
formation.
Rescue of infectious virus containing the F0
cleavage site mutations
The pCIneo plasmids with the five different F0 cleavage site
mutations were used to introduce these mutations into full-
length NDV cDNA in plasmid pNDFL (see Methods). The
resulting plasmids were named pNDFL-FFM, pNDFL-FFM1,
pNDFL-FFM2, pNDFL-FFM3 and pNDFL-FFM4.
These plasmids were used to generate infectious NDV with
the different F0 cleavage site mutations (see Methods). The
supernatants of transfected monolayers were used to
inoculate the allantoic cavities of 8–11-day-old embryo-
nated SPF eggs. The allantoic fluid was harvested 4 days after
infection and analysed in a HA assay. Allantoic fluid with a
positive HA titre was used for the isolation of the viral RNA
genome followed by sequence analysis of an RT-PCR
fragment that covered the F0 cleavage site. The results
showed that all NDFL F0 cleavage site mutants could be
recovered from cloned full-length cDNA. The mutants grew
to similar titres compared with the parent strain, and the
sequences of the F0 cleavage sites were still intact after two
passages in embryonated eggs (data not shown).
The F0 cleavage site mutants were used to examine plaque
formation on CEF cells. None of the mutants produced
plaques 3 days post-inoculation except for the positive
controls NDFLtag (RRQRRQF) (Peeters et al., 1999) and
NDFL-FFM5 (RRQKRQF) (for details of FFM5, see below)
(Fig. 1; data for FFM1 are not shown). All other mutations
gave rise to single-cell infections, indicating that the F0
protein was not cleaved.
Determination of the effect of the F0 cleavage
site mutations on virulence
Next we tested the virulence of the newly generated strains
by determining the ICPI in 1-day-old chickens. Table 2(a)
shows that the ICPI values of the NDV fusion cleavage site
mutants varied from 0?0 for NDFL-FFM1 to 1?1 for NDFL-
FFM3. With the exception of NDFL- FFM1, all the NDV fusion
cleavage site mutants showed a delay in morbidity and
mortality compared with virulent strain NDFLtag during
the observation period of 8 days of the ICPI experiment. For
mutants NDFL-FFM, NDFL-FFM2 and NDFL-FFM4, mortal-
ity increased further after day 8 (data not shown).
Organ material from dead chickens from the different ICPI
experiments was used for virus re-isolation. After one egg
passage, the nucleotide sequence of the fusion cleavage site
was determined. The sequence data showed that all cleavage
sites had reverted to the velogenic type RRQRRQF with the
exception of the double mutant of NDFL-FFM4. In this
strain, only the lysine at position 113 had reverted to an
arginine, which resulted in the velogenic cleavage site
(RRQKRQF) (Table 2b). These results indicated that all of
the cleavage sites reverted to the consensus amino acid
sequence of virulent strains after one passage in the chicken
brain.
To determine the phenotype of the revertants in cell culture,
CEF cells were infected with the revertants and examined for
plaque formation. Plaque formation was observed for all the
revertants after 3 days (Fig. 1), which indicated that the
revertant F0 proteins had been cleaved as for the F0 protein
of NDFLtag.
Increase in virulence of NDV after one passage
in chicken brains
The revertant NDV strains, which were called NDFL-FFMR,
NDFL-FFM2R, NDFL-FFM3R and NDFL-FFM4R, were again
used to determine the ICPI. The resulting ICPI values varied
from 1?4 to 1?7 (Table 2b), well above the value of the
parent strain NDFLtag, which has the same cleavage site
(RRQRRQF) but which has an ICPI value of 1?3. The
revertant NDV strains were propagated in embryonated
eggs and again used for sequence analysis of the F0 cleavage
site. These sequence analyses showed no further alteration
of the F0 cleavage sites.
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Fig. 1. Plaques produced in a CEF cell monolayer by NDV F0 cleavage site mutants before (A) and after (B) a passage in
chicken brains. CEF cells were infected with virus and incubated for 3 days under a 1 % methylcellulose overlay containing
5 % FCS and antibiotics. Plaques were visualized by immunological staining (Wensvoort et al., 1986) using a mAb against the
NDV F protein. Magnification 625.
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The complete sequence of the F0 gene of strain NDFL-FFM4R
was determined and compared with the sequence of the F0
gene of the parent strain NDFL-FFM4 and of the cDNA of
pNDFL-FFM4. This analysis showed that no other mutations
were present in the F gene except for the one in the cleavage
site. This means that the increase in virulence of the
revertant NDV strains is not caused by another mutation in
the F0 gene but probably by a mutation(s) elsewhere in the
NDV genome.
To confirm that the virulence indeed increases after one
passage in chicken brains, we determined the ICPI of isolate
NDFLtagPass, which was recovered after one passage of
strain NDFLtag in chicken brains. The ICPI value increased
from 1?3 (NDFLtag) to 1?5 (NDFLtagPass) (Table 2a, b).
Nucleotide sequence analysis showed that the F0 cleavage
site of strain NDFLtagPass was identical to that of NDFLtag.
Additional proof for increase in virulence was obtained by
generating NDFL-FFM5, which has the same cleavage site as
NDFL-FFM4R (RRQKRQF). The ICPI value of NDFL-FFM5
was found to be 1?3, which is equal to that of NDFLtag. This
means that the lysine (K) instead of the arginine (R) at
position 115 does not have any effect on the virulence.
However, after one passage of NDFL-FFM5 in chicken brain,
the ICPI of the re-isolate (NDFL-FFM5Pass) also showed an
increase in the ICPI from 1?3 to 1?5. In this case also,
nucleotide sequence analysis showed that the F0 cleavage site
of strain NDFL-FFM5Pass was similar to that of NDFL-FFM5
(Table 2a, b). Although the virulence of NDV increased
after a passage in chicken brains, significant differences in
plaque size, for example between NDFLtag and NDFLtagPass,
on CEF cells could not be observed.
DISCUSSION
In this study we generated infectious NDV from cloned
cDNA with mutations in the protease cleavage site of the F0
protein (Table 1). These protease cleavage sites are distinct
from the consensus sequence of the cleavage site of
velogenic/mesogenic field isolates, which are characterized
by dibasic amino acids flanking the glutamine (Q114) and a
phenylalanine (F117) as the first amino acid of the F1 protein
Table 2. ICPI of the NDV F0 cleavage site mutants
(a) After one passage in embryonated eggs
NDV F0 cleavage Cleavage
Days
site mutants site* HA titre3 P.f.u.4 Clinical view 1 2 3 4 5 6 7 8 Score1
NDFL GRQGRL 7 8?1 Normal 10 10 10 10 10 10 10 10
Sick
Dead
0
NDFLtag RRQRRF 5 6?5 Normal 10 10 1
Sick 10 5 1
Dead 4 9 10 10 10
1?3
NDFL-FFM RRQRRL 6 7?5 Normal 10 10 10 10 7 2 1
Sick 3 7 9 5
Dead 1 1 4
0?5
NDFL-FFM1 GRQGRF 7 7?5 Normal 10 10 10 10 10 10 10 10
Sick
Dead
0
NDFL-FFM2 RRQGRF 6 7?7 Normal 10 10 10 9 8 7 6 5
Sick 1 2 1 2 3
Dead 2 2 2
0?3
NDFL-FFM3 RGQRRF 7 7?3 Normal 10 10 10 2
Sick 5 4
Dead 3 6 10 10 10
1?1
NDFL-FFM4 RKQKRF 7 7?2 Normal 10 10 10 9 7 4 2 1
Sick 1 3 5 5 4
Dead 1 3 5
0?5
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112R/K-R-Q-R/K-R-F117. To investigate which amino acids
are important for cleavage of the F0 protein by host-cell
protease(s), the mutants FFM1 (GRQGRQF), FFM2
(RRQGRQF) and FFM3 (RGQRRQF) were generated. In
these mutants, one or two basic amino acid residues were
replaced by a non-basic amino acid. In mutant FFM4
(RKQKRQF), the pair of basic amino acid residues was not
changed, but the type of the amino acid residue was changed
from an arginine into a lysine at amino acid positions 113
and 115. Mutation FFM (RRQRRQL) was generated to
investigate the effect of changing the amino acid at position
117 from a phenylalanine into a leucine.
Compared with the parent strain, all the newly generated
NDV F0 mutants grew to similar titres in the allantoic cavity
of embryonated eggs. Sequence analysis of the cleavage sites
of the F0 mutants showed that no change occurred after two
egg passages. This indicated that the allantoic fluid of the
chicken egg contains a trypsine-like protease that is able to
cleave the mutant F0 proteins shown in Table 1. However,
transient expression of the mutant F0 proteins together with
the HN protein did not result in syncytium formation of
QM5 cells. This suggests that the mutant cleavage sites
behaved like the lentogenic cleavage site of FLS (La Sota).
Only FWT protein induced syncytium formation, indicating
that it was cleaved by the host-cell protease (Table 1). The
same lentogenic behaviour of the F0 cleavage site mutants
was observed at the whole-virus level after examining plaque
formation on CEF cells (Fig. 1A).
To analyse the effect of the mutant cleavage sites on
virulence, the ICPI was determined (Table 2a). Interes-
tingly, even though the ICPI values were all below the value
of the parent strain NDFLtag (ICPI51?3), they were much
higher than expected based on the lentogenic behaviour of
the F0 cleavage site mutants. These high ICPI values were
caused by a dramatic increase in morbidity and mortality
after day 5 for most of the NDV F0 cleavage site mutants
(Table 2a). This increase in morbidity and mortality was the
result of the presence of revertants with an F0 cleavage site
RRQ(K/R)RQF. These revertants are the result of replica-
tion errors and were probably already present after virus
propagation in eggs. Apparently the cells in chicken brain
constitute a highly selective environment for NDV viruses
with the velogenic F0 cleavage site RRQ(K/R)RQF. Initially,
the ICPI values indicated that the cleavage site mutants were
Table 2. (cont.)
(b) Re-isolated from dead birds in the first ICPI test
Viruses were passaged once in embryonated eggs before the second ICPI test was determined.
NDV F0 cleavage Cleavage
Days
site mutants site|| HA titre P.f.u. Clinical view 1 2 3 4 5 6 7 8 Score
NDFLtagPass* RRQRRF 9 6?0 Normal 10 4
Sick 6 5
Dead 5 10 10 10 10 10
1?5
NDFL-FFMR RRQRRF 6 7?1 Normal 9 8
Sick 1 2 9
Dead 0 0 1 10 10 10 10 10
1?4
NDFL-FFM2R RRQRRF 6 6?0 Normal 9
Sick 1 2
Dead 8 10 10 10 10 10 10
1?7
NDFL-FFM3R RRQRRF 7 6?8 Normal 10 9
Sick 1 7
Dead 3 10 10 10 10 10
1?4
NDFL-FFM4R RRQKRF 5 6?3 Normal 10
Sick 10 2
Dead 8 10 10 10 10 10
1?6
*The modified amino acids in the cleavage sites are underlined.
3Haemagglutination titres (log2).
4Titres (log10) expressed as p.f.u. ml
21.
||The resulting amino acid changes after the ICPI test are shown in bold.
1ICPI score5[(total numbers of sick chickens 61)+(total number of dead chickens 62)]/80 observations.
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either lentogenic or mesogenic. But in fact these values were
influenced by the presence of virulent revertants. Therefore,
precautions must be taken when the ICPI of strains
containing cleavage site mutations is determined. It is
sensible to sequence the F0 cleavage site of the re-isolate
from dead chickens after the ICPI test to be sure that the
amino acid sequence of the cleavage site is identical before
and after the ICPI test.
The ICPIs of the velogenic revertants were all above the ICPI
of the parent NDFLtag (ICPI51?3). However, the fusion
cleavage site of NDFLtag is the same as the fusion cleavage
site of NDFL-FFM2R (ICPI51?7) and NDFL-FFM3R
(ICPI51?5). Sequence analysis of the entire F0 gene of
NDFL-FFM4, NDFL-FFM4R and pNDFL-FFM4 did not show
any mutations other than the mutations of the cleavage site.
This suggests that the revertants have somehow adapted to
the host cells after one passage in the chicken brain. This
might be due to another mutation somewhere in the NDV
genome that results in an increase of the ICPI. NDFLtagPass
and NDFL-FFM5Pass indeed showed an increase in ICPI
compared with NDFLtag and NDFL-FFM5, respectively,
whereas the cleavage sites remained unaltered. Thus, the
pathogenicity of NDV is not only related to the F0 cleavage
site. A similar increase in virulence has been observed by
Collins et al. (1994) for a variant of NDV, PPMV-1.
Similarly, in this case the F0 cleavage site of PPMV-1 isolates
did not change after passage in chickens.
From our results, it is clear that the amino acid sequence
112R-R-Q-K/R-R-F117 is required for efficient cleavage of the
velogenic/mesogenic F0 protein by a furin-like protease in
chicken tissues. This amino acid sequence is identical to the
consensus amino acid sequence 112R/K-R-Q-R/K-R-F117 of
virulent NDV strains. Interestingly, a basic lysine (K) at
amino acid position 113 is not accepted by this protease. In
agreement with this observation, a K at position 113 has
never been observed in field isolates. Thus, whereas the
dibasic combination K-R at amino acid positions 112 and
113 does exist, the combination R-K does not. The dibasic
structure at amino acid positions 112 and 113 was not
required for some velogenic strains that were isolated from
pigeons (PPMV-1) and had the fusion cleavage site GRQ(K/
R)RQF (Collins et al., 1994). Surprisingly, the F0 cleavage
mutant NDFL-FFM1 (GRQGRQF) did not revert to
GRQ(K/R)RQF, even though just a single nucleotide
mutation is needed to change the amino acid at position
115 from a G (codon5 GGG) to an R (codon5CGG). Fujii
et al. (1999) demonstrated with F0 cleavage site mutants
expressed by vaccinia virus vectors in CEF cells that the R
residue at position 112 was only required for maximal
cleavage by the host-cell protease. This also suggested that
the revertant of NDFL-FFM1 could exist. The fact that the
revertant did not appear after intracerebral inoculation
could indicate that the cleavage site GRQ(K/R)RQF of
NDFL-FFM1, in contrast to the pigeon isolate with the same
cleavage site, is not virulent.
It is clear that our NDV F0 cleavage site mutants give rise to
revertants with a velogenic cleavage site by point mutations.
After just one passage in chicken brains, we were able to
isolate such revertants. This evolution of the NDV F0
cleavage site is reminiscent of the emergence of virulent
strains, which were responsible for the outbreaks of
Newcastle disease in Ireland in 1990 (Alexander et al.,
1992) and in Australia in the years 1998–2000 (Gould et al.,
2001; Westbury, 2001). Analysis of these virulent NDV
isolates showed that they were closely related to a lentogenic
strain (antigenically and genetically) that was considered to
be the precursor of the virulent virus. The Australian NDV
isolate Peats Ridge with the cleavage site RRQGRQL pro-
bably required two mutations to evolve via RRQRRQL
(Somersby), RRQKRQL (MP-2000) or RRQGRQF (PR-32)
to the velogenic site RRQ(K/R)RQF. Toyoda et al. (1989)
have already concluded that different strains of NDV have
evolved through various degrees of accumulation of point
mutations rather than gene exchange by recombination.
We have shown in this study that NDV can evolve from a
non-virulent type to a virulent type by point mutations. At
this moment, there is no evidence that this frequently
happens in the field. One reason for this is that the chance of
accumulating three mutations from GRQGRQL to (K/
R)RQ(R/K)RQF is probably very low. This is confirmed by
NDFL-FFM1 (GRQGRQF), which needs just two mutations
but did not revert to a virulent strain. A second reason is the
fact that mutations to virulence have only been observed in a
relatively small non-vaccinated chicken population (in a
country like Australia) and never in an immune population.
This might be explained by the low transmission of mutants
in vaccinated populations. Furthermore, it is not clear where
mutations to virulence occur in the field. Do the mutations
take place in feral birds and are then passed to poultry or do
they occur once the virus has been introduced in poultry?
In this study, the NDV F0 cleavage site mutants were
propagated in embryonated eggs followed by a passage in
chicken brains where the virulent revertants appeared. This
is far from the natural infection route of NDV and therefore
it is of interest to know whether NDV F0 cleavage site
mutants give rise to revertants when the natural infection
route, i.e. the respiratory tract, is used.
Nevertheless, attention must be paid when a non-virulent
NDV strain is isolated from the field that has just one or
two amino acid differences in the F0 cleavage site compared
with a virulent strain. Such NDV strains can evolve to a
virulent strain, which can cause devastating disease in
poultry.
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